DexCom CEO Kevin Sayer's 2019 pay rises 8% to $10M
DexCom reports 2019 executive compensation
By ExecPay News
Published: April 10, 2020
DexCom reported fiscal year 2019 executive compensation information on April 10, 2020.
In 2019, five DexCom executives received on average a compensation package of $4.7M, a 4% increase compared to previous year.
Average pay of disclosed executives at DexCom
Kevin Sayer, Chief Executive Officer, received $10M in total, which increased by 8% compared to 2018. 80% of Sayer's compensation, or $8.2M, was in stock awards. Sayer also received $1.4M in non-equity incentive plan, $691K in salary, as well as $19K in other compensation.
For fiscal year 2019, the median employee pay was $94,523 at DexCom. Therefore, the ratio of Kevin Sayer's pay to the median employee pay was 109 to one.
Quentin S. Blackford, Chief Financial Officer, received a compensation package of $3.8M, which increased by 12% compared to previous year. 69% of the compensation package, or $2.6M, was in stock awards.
Richard Doubleday, EVP, Chief Commercial Officer, earned $3.3M in 2019, a 2% increase compared to previous year.
Andrew Balo, EVP, Regulatory Strategy, Clinical Affairs, and Strategic Partnership Development, received $3M in 2019, which decreases by 5% compared to 2018.
Steven R. Pacelli, EVP, Strategy and Corporate Development, earned $3M in 2019, a 5% decrease compared to previous year.
Related executives
Kevin Sayer
DexCom
Chief Executive Officer
Quentin Blackford
DexCom
Chief Financial Officer
Andrew Balo
DexCom
EVP, Regulatory Strategy, Clinical Affairs, and Strategic Partnership Development
Richard Doubleday
DexCom
EVP, Chief Commercial Officer
Steven Pacelli
DexCom
EVP, Strategy and Corporate Development
You may also like
Source: SEC filing on April 10, 2020.